Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms that underlie tumour progression are still poorly understood, but recently our knowledge of particular aspects of some of these processes has increased. Specifically, the identification of Snail, ZEB and some basic helix-loop-helix (bHLH) factors as inducers of epithelial-mesenchymal transition (EMT) and potent repressors of E-cadherin expression has opened new avenues of research with potential clinical implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides SNAIL-1, TGF-β, via a SMAD-dependent pathway, mediates the activation of Twist and ZEB-1 factors, which in turn can downregulate E-cadherin expression [27].”
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms
Massari, M. E., & Murre, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.429-440.2000 · Cited by 1,816
Cited by
Items 301–400 of 1,011
Evolutionary functional analysis and molecular regulation of the ZEB transcription factors
Gheldof, A., Hulpiau, P., van Roy, F., De Craene, B., & Berx, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0935-3 · Cited by 177
Zhang, H., Meng, F., Liu, G., Zhang, B., Zhu, J., Wu, F., Ethier, S. P., Miller, F., & Wu, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2825 · Cited by 177
Pereira, F., Barbáchano, A., Silva, J., Bonilla, F., Campbell, M. J., Muñoz, A., & Larriba, M. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr399 · Cited by 177
“The finding that JMJD3 knockdown affected CDH1/ E-cadherin expression and cell phenotype led us to investigate the possibility that these effects could be due to the regulation of genes such as SNAI1, SNAI2, ZEB1 or ZEB2 encoding transcriptional repressors (SNAIL1, SNAIL2, ZEB1, ZEB2) of CDH1/E-cadherin that are EMT i…”
BackgroundNew Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00004-5 · Cited by 176
Hill, C., Li, J., Liu, D., Conforti, F., Brereton, C. J., Yao, L., Zhou, Y., Alzetani, A., Chee, S. J., Marshall, B. G., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1820-x · Cited by 175
IGFBP2: integrative hub of developmental and oncogenic signaling network
Li, T., Forbes, M. E., Fuller, G. N., Li, J., Yang, X., & Zhang, W. (2020) · Oncogene · doi:10.1038/s41388-020-1154-2 · Cited by 175
Metastasis suppressors genes in cancer
Stafford, L. J., Vaidya, K. S., & Welch, D. R. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.016 · Cited by 175
Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review
Perlikos, F., Harrington, K. J., & Syrigos, K. N. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.12.007 · Cited by 174
The epithelial polarity program: machineries involved and their hijacking by cancer
Tanos, B., & Rodriguez-Boulan, E. (2008) · Oncogene · doi:10.1038/onc.2008.345 · Cited by 174
Direct reprogramming of stem cell properties in colon cancer cells by CD44
Su, Y., Lai, H., Chang, Y., Chen, G., & Lee, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.211 · Cited by 174
Epithelial–Mesenchymal Transition in Ovarian Carcinoma
Davidson, B., Tropé, C. G., & Reich, R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00033 · Cited by 173
TGF-β, EMT, and resistance to anti-cancer treatment
Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.004 · Cited by 170
Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
Silva, L. D., Parry, S., Reid, L., Keith, P., Waddell, N., Kossai, M., Clarke, C., Lakhani, S. R., & Simpson, P. T. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318158d6c5 · Cited by 173
Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
Cheng, J.-T., Wang, L., Wang, H., Tang, F.-R., Cai, W.-Q., Sethi, G., Xin, H.-W., & Ma, Z. (2019) · Cells · doi:10.3390/cells8101178 · Cited by 172
Carraro, G., El-Hashash, A., Guidolin, D., Tiozzo, C., Turcatel, G., Young, B. M., De Langhe, S. P., Bellusci, S., Shi, W., Parnigotto, P. P., et al. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.06.020 · Cited by 171
Moes, M., Le Béchec, A., Crespo, I., Laurini, C., Halavatyi, A., Vetter, G., del Sol, A., & Friederich, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035440 · Cited by 172
Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA
Ghafouri-Fard, S., & Taheri, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109129 · Cited by 172
Non-coding RNAs: the new central dogma of cancer biology
Saw, P. E., Xu, X., Chen, J., & Song, E.-W. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1700-9 · Cited by 171
“Snail1, Slug, ZEB1, and SIP1 (ZEB2) are major transcription factors that repress E-cadherin either directly or indirectly to promote EMT.”
BackgroundInfluentialLiu, M., Casimiro, M. C., Wang, C., Shirley, L. A., Jiao, X., Katiyar, S., Ju, X., Li, Z., Yu, Z., Zhou, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910009106 · Cited by 171
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
Lundgren, K., Nordenskjöld, B., & Landberg, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605369 · Cited by 171
The Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation
Viñas-Castells, R., Beltran, M., Valls, G., Gómez, I., García, J. M., Montserrat-Sentís, B., Baulida, J., Bonilla, F., de Herreros, A. G., & Díaz, V. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065995 · Cited by 170
Knauf, J. A., Sartor, M. A., Medvedovic, M., Lundsmith, E., Ryder, M., Salzano, M., Nikiforov, Y. E., Giordano, T. J., Ghossein, R. A., & Fagin, J. A. (2011) · Oncogene · doi:10.1038/onc.2011.44 · Cited by 170
Drasin, D. J., Robin, T. P., & Ford, H. L. (2011) · Breast Cancer Research · doi:10.1186/bcr3037 · Cited by 168
“High levels of ZEB1/2 have similarly been found to correlate with poor survival, outcome and grade in numerous cancers, including breast [35,36].”
BackgroundFOXQ1 Regulates Epithelial-Mesenchymal Transition in Human Cancers
Qiao, Y., Jiang, X., Lee, S. T., Karuturi, R. K. M., Hooi, S. C., & Yu, Q. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2787 · Cited by 168
Battistelli, C., Cicchini, C., Santangelo, L., Tramontano, A., Grassi, L., Gonzalez, F. J., de Nonno, V, Grassi, G., Amicone, L., & Tripodi, M. (2017) · Oncogene · doi:10.1038/onc.2016.260 · Cited by 168
Epithelial-to-mesenchymal transition in the development of endometriosis
Yang, Y.-M., & Yang, W.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.16472 · Cited by 167
“Except for Twist, these transcription factors could repress expression of E-cadherin by directly binding to the E-box sites in its promoter [24].”
BackgroundHuang, Z., Zhang, Z., Zhou, C., Liu, L., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.144 · Cited by 166
Yoshihara, K., Tajima, A., Komata, D., Yamamoto, T., Kodama, S., Fujiwara, H., Suzuki, M., Onishi, Y., Hatae, M., Sueyoshi, K., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01204.x · Cited by 167
DaSilva-Arnold, S., James, J. L., Al-Khan, A., Zamudio, S., & Illsley, N. P. (2015) · Placenta · doi:10.1016/j.placenta.2015.10.013 · Cited by 167
Mechanisms of malignant progression
Weinberg, R. A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn104 · Cited by 167
Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164
SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition
Hahn, S., Jackstadt, R., Siemens, H., Hünten, S., & Hermeking, H. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.236 · Cited by 165
“The effects of ectopic ZNF281 were not due to increased proliferation, since ZNF281 activation had a slight anti-proliferative effect (Supplementary Figure S5), which has also been described for other EMT-TFs, such as SNAIL (Peinado et al , 2007).”
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
Cano, A., Diaz-Lopez, A., & Moreno-Bueno, G. (2014) · Cancer Management and Research · doi:10.2147/cmar.s38156 · Cited by 165
Potential therapeutic targets of epithelial–mesenchymal transition in melanoma
Pearlman, R. L., Montes de Oca, M. K., Pal, H. C., & Afaq, F. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.029 · Cited by 165
Phenotype Switching in Melanoma: Implications for Progression and Therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163
“The expression of E-cadherin is tightly regulated by multiple transcription factors that bind to and repress the activity of the E-cadherin promoter (8, 9).”
BackgroundOhashi, S., Natsuizaka, M., Wong, G. S., Michaylira, C. Z., Grugan, K. D., Stairs, D. B., Kalabis, J., Vega, M. E., Kalman, R. A., Nakagawa, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4614 · Cited by 164
De Smedt, L., Palmans, S., Andel, D., Govaere, O., Boeckx, B., Smeets, D., Galle, E., Wouters, J., Barras, D., Suffiotti, M., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.382 · Cited by 163
“However, b-catenin is not the sole inducer of SNAIL, ZEB and TWIST expression (Peinado et al, 2007; Xu et al, 2009; Dawson and Lugli, 2015).”
BackgroundWang, G., Guo, X., Hong, W., Liu, Q., Wei, T., Lu, C., Gao, L., Ye, D., Zhou, Y., Chen, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212769110 · Cited by 149
“The best characterized role of ZEB2 is the induction of cell transformation and metastasis during the induction of EMT process, a phenomenon occurring normally during embryonic development, wound healing, and carcinogenesis (39).”
BackgroundSlug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Chang, T.-H., Tsai, M.-F., Su, K.-Y., Wu, S.-G., Huang, C.-P., Yu, S.-L., Yu, Y.-L., Lan, C.-C., Yang, C.-H., Lin, S.-B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1440oc · Cited by 163
Celià-Terrassa, T., Bastian, C., Liu, D. D., Ell, B., Aiello, N. M., Wei, Y., Zamalloa, J., Blanco, A. M., Hang, X., Kunisky, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07538-7 · Cited by 161
Kitai, H., Ebi, H., Tomida, S., Floros, K. V., Kotani, H., Adachi, Y., Oizumi, S., Nishimura, M., Faber, A. C., & Yano, S. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1377 · Cited by 162
“Hallmarks of EMT include the loss of E-cadherin expression and concomitant increase of mesenchymal markers such as vimentin (15,16).”
BackgroundMa, Z., & Vosseller, K. (2013) · Amino Acids · doi:10.1007/s00726-013-1543-8 · Cited by 162
Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis
Wang, Y., & Zhou, B. P. (2013) · Cancer Hallmarks · doi:10.1166/ch.2013.1004 · Cited by 161
Yap1 Is Required for Endothelial to Mesenchymal Transition of the Atrioventricular Cushion
Zhang, H., von Gise, A., Liu, Q., Hu, T., Tian, X., He, L., Pu, W., Huang, X., He, L., Cai, C.-L., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554584 · Cited by 162
“Epithelial cells, under the influence of TGF and other signaling pathways, undergo nuclear reprogramming involving several transcription factors, such as Snail, Twist1, Slug, ZEB1, and ZEB2 (7).”
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Cochrane, D. R., Howe, E. N., Spoelstra, N. S., & Richer, J. K. (2010) · Journal of Oncology · doi:10.1155/2010/821717 · Cited by 162
A step-by-step microRNA guide to cancer development and metastasis
Markopoulos, G. S., Roupakia, E., Tokamani, M., Chavdoula, E., Hatziapostolou, M., Polytarchou, C., Marcu, K. B., Papavassiliou, A. G., Sandaltzopoulos, R., & Kolettas, E. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0341-9 · Cited by 161
“Zeb1 is a strong inducer of tumor cell invasion and has been found to be necessary for metastasis in animal models [323].”
BackgroundJin, M., Wang, J., Ji, X., Cao, H., Zhu, J., Chen, Y., Yang, J., Zhao, Z., Ren, T., & Xing, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1135-x · Cited by 162
Ding, X., Park, S. I., McCauley, L. K., & Wang, C.-Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.443655 · Cited by 161
“A family of E-box-binding transcription factors, including SNAI1, SNAI2, ZEB1, ZEB2, and TWIST1, have been found to promote EMT and tumor metastasis by repressing CDH1 (8).”
BackgroundFra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression
Bakiri, L., Macho-Maschler, S., Custic, I., Niemiec, J., Guío-Carrión, A., Hasenfuss, S. C., Eger, A., Müller, M., Beug, H., & Wagner, E. F. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.157 · Cited by 161
Singh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1309 · Cited by 161
Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs
Rowe, R. G., Li, X.-Y., Hu, Y., Saunders, T. L., Virtanen, I., de Herreros, A. G., Becker, K.-F., Ingvarsen, S., Engelholm, L. H., Bommer, G. T., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200810113 · Cited by 161
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
Liu, T., Yu, J., Deng, M., Yin, Y., Zhang, H., Luo, K., Qin, B., Li, Y., Wu, C., Ren, T., et al. (2017) · Nature Communications · doi:10.1038/ncomms13923 · Cited by 161
Si, W., Huang, W., Zheng, Y., Yang, Y., Liu, X., Shan, L., Zhou, X., Wang, Y., Su, D., Gao, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.011 · Cited by 160
“The two vertebrate ZEB transcription factors, ZEB1 and ZEB2, can either repress or activate transcription (Peinado et al., 2007).”
BackgroundInfluentialCrosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
Lindsey, S., & Langhans, S. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00358 · Cited by 159
“Molecular events during EMT result in transcriptional regulation of the transcription factors Snail (Snail1), Slug (Snail2), zincfinger E-box-binding homeobox (ZEB)1/2, and Twist1/2, leading to a molecular fingerprint that serves as a phenotypic marker during EMT (14).”
BackgroundYori, J. L., Johnson, E., Zhou, G., Jain, M. K., & Keri, R. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114546 · Cited by 159
Zhang, J.-P., Zeng, C., Xu, L., Gong, J., Fang, J.-H., & Zhuang, S.-M. (2014) · Oncogene · doi:10.1038/onc.2013.369 · Cited by 160
Expanding roles of ZEB factors in tumorigenesis and tumor progression.
Sànchez‐Tilló, E., Siles, L., de Barrios, O., Cuatrecasas, M., Vaquero, E. C., Castells, A., & Postigo, A. A. (2011) · Europe PMC (PubMed Central) · Cited by 209
Moreno‐Bueno, G., Salvador, F., Martín, A., Floristán, A., Cuevas, E. P., Santos, V., Montes, A., Morales, S., Castilla, M. A., Rojo‐Sebastián, A., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100156 · Cited by 158
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Ahn, Y.-H., Gibbons, D. L., Chakravarti, D., Creighton, C. J., Rizvi, Z. H., Adams, H. P., Pertsemlidis, A., Gregory, P. A., Wright, J. A., Goodall, G. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63608 · Cited by 156
Sato, R., Semba, T., Saya, H., & Arima, Y. (2016) · Stem Cells · doi:10.1002/stem.2406 · Cited by 172
Lü, Q., Ji, X., Zhou, Y., Yao, X., Liu, Y., Zhang, F., & Yin, X. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.006 · Cited by 167
Villarejo, A., Cortés-Cabrera, Á., Molina-Ortíz, P., Portillo, F., & Cano, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528026 · Cited by 173
Kawauchi, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13044564 · Cited by 187
Xia, L., Huang, W., Tian, D., Zhang, L., Qi, X., Chen, Z., Shang, X. C., Nie, Y., & Wu, K. (2013) · Hepatology · doi:10.1002/hep.26735 · Cited by 156
“Several transcription factors have been identified as critical regulator of this process, including Snai1, Slug, ZEB1, ZEB2/SIP1, Twist, and E49.”
BackgroundJohansson, J., Berg, T., Kurzejamska, E., Pang, M.-F., Tabor, V, Jansson, M., Roswall, P., Pietras, K., Sund, M., Religa, P., et al. (2013) · Oncogene · doi:10.1038/onc.2013.322 · Cited by 153
LONG, X., YE, Y., ZHANG, L., LIU, P., YU, W., WEI, F., REN, X., & YU, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2015.3234 · Cited by 153
Han, M., Zhao, Y., Tan, C., Xiong, Y., Wang, W., Wu, F. Y., Yao, F., Wang, L., & Liang, Z. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.93 · Cited by 156
aV integrins and TGF‐β‐induced EMT: a circle of regulation
Mamuya, F. A., & Duncan, M. K. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01419.x · Cited by 184
Liu, T., Ma, W., Xu, H., Huang, M., Zhang, D., He, Z., Zhang, L., Brem, S., O’Rourke, D. M., Gong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05982-z · Cited by 151
Bonavida, B., Baritaki, S., Huerta‐Yépez, S., Vega, M. I., Chatterjee, D., & Yeung, K. C. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.018 · Cited by 163
Zhang, J., Zhang, H., Liu, J., Tu, X., Zang, Y., Zhu, J., Chen, J., Dong, L., & Zhang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.121 · Cited by 168
Wu, C., Tsai, Y., Wu, M.-Z., Teng, S., & Wu, K. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.05.005 · Cited by 163
Sun, Y., Shen, S., Liu, X., Tang, H., Wang, Z., Yu, Z., Li, X., & Wu, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1950-x · Cited by 157
Liu, H., Ren, G., Wang, T., Chen, Y., Gong, C., Bai, Y., Wang, B., Qi, H., Shen, J., Zhu, L., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv017 · Cited by 156
“Thus, Fra-1 plays an important role in promoting aggressive behavior in CRC cells through the EMT-TFs and MMPs. Increased Fra-1 expression is associated with cancer aggressiveness and activated IL-6/STAT3 signaling in CRC samples Immunohistochemical staining was performed to evaluate the clinical relevance of Fra-1 ex…”
BackgroundInfluentialSarrio, D., Franklin, C. K., Mackay, A., Reis-Filho, J. S., & Isacke, C. M. (2012) · Stem Cells · doi:10.1002/stem.791 · Cited by 149
AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
Jackstadt, R., Röh, S., Neumann, J., Jung, P., Hoffmann, R., Horst, D., Berens, C., Bornkamm, G. W., Kirchner, T., Menssen, A., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20120812 · Cited by 150
“Because we had identified SNAIL, which encodes an EMTinducing transcription factor, as a direct AP4 target and EMT transcription factors often form redundant, regulatory networks (Peinado et al., 2007), we determined whether AP4 and SNAIL are functionally interdependent.”
BackgroundInfluentialProtein Kinase D1 Suppresses Epithelial-to-Mesenchymal Transition through Phosphorylation of Snail
Du, C., Zhang, C., Hassan, S., Biswas, M. H. U., & Balaji, K. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4481 · Cited by 150
Fu, J., Rodova, M., Roy, S. K., Sharma, J. P., Singh, K. P., Srivastava, R. K., & Shankar, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.018 · Cited by 157
Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
Pearson, G. W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050646 · Cited by 172
“Snail, Slug, Zeb1, and Zeb2 directly bind E-Box recognition sites in the E-cadherin promoter [26] and recruit histone methyltransferases, demethylases, and deacetylases to create a repressed chromatin architecture that drastically reduces or eliminates E-cadherin expression [27].”
BackgroundEmerging Biomarkers for Early Detection of Chronic Kidney Disease
Mizdrak, M., Kumrić, M., Kurir, T. T., & Božić, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040548 · Cited by 191
Makrodouli, E., Oikonomou, E., Koc, M., Andera, L., Sasazuki, T., Shirasawa, S., & Pintzas, A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-118 · Cited by 147
Sánchez‐Duffhues, G., de Vinuesa, A. G., & ten Dijke, P. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24589 · Cited by 148
“…consisting of four to six E2-box DNA binding zinc fingers, a N-terminal protein-interaction domain (SNAG domain) required for the transcriptional repressor activity, and a central domain that can be posttranslationally modified to regulate protein stability or localization (Peinado et al., 2007).”
BackgroundYao, L., Conforti, F., Hill, C. N., Bell, J., Drawater, L., Li, J., Liu, D., Xiong, H., Alzetani, A., Chee, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0175-7 · Cited by 155
Li, N., Babaei-Jadidi, R., Lorenzi, F., Spencer-Dene, B., Clarke, P., Domingo, E., Tulchinsky, E., Vries, R. G. J., Kerr, D., Pan, Y., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0125-3 · Cited by 147
Hill, C., Jones, M., Davies, D., & Wang, Y. (2019) · Journal of Lung Health and Diseases · doi:10.29245/2689-999x/2019/2.1149 · Cited by 146
Bae, G.-Y., Choi, S., Lee, J., Jo, J., Lee, J., Kim, J., & Cha, H. (2013) · Oncotarget · doi:10.18632/oncotarget.1463 · Cited by 158
“Of note, a simple E-cadherin knockdown was able to promote the expression of several transcription factors such as TWIST1, SLUG, and ZEB1, which serve as typical EMT inducers [14] (Fig.”
BackgroundWu, J., Ru, N.-Y., Zhang, Y., Li, Y., Wei, D., Ren, Z., Huang, X.-F., Chen, Z.-N., & Bian, H. (2011) · Oncogene · doi:10.1038/onc.2011.149 · Cited by 162
Aigner, A. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0716-0 · Cited by 152
Coppola, V., Maria, R. D., & Bonci, D. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0172 · Cited by 173
Identification of blood vascular endothelial stem cells by the expression of protein C receptor
Yu, Q. C., Song, W., Wang, D., & Zeng, Y. A. (2016) · Cell Research · doi:10.1038/cr.2016.85 · Cited by 146
Tang, S., Yin, Q., Su, J., Sun, H., Meng, Q., Chen, Y., Chen, L., Huang, Y., Gu, W., Xu, M., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.049 · Cited by 148
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
Strippoli, R., Moreno-Vicente, R., Battistelli, C., Cicchini, C., Noce, V., Amicone, L., Marchetti, A., del Pozo, M. Á., & Tripodi, M. (2016) · Stem Cells International · doi:10.1155/2016/3543678 · Cited by 162
“They often have some tissue specificity but similar mechanism of action [85].”
New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
Fabregat, I., Malfettone, A., & Soukupova, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030037 · Cited by 145
Epigenetic regulation of epithelial–mesenchymal transition
Sun, L., & Fang, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2303-1 · Cited by 160
“A cohort of transcription factors, including two double zinc finger and homeodomain factors (ZEB1/2, the Snail family of zinc finger proteins (SNAI1/2/3), and the family of bHLH factors (TWIST1/2, E12/E47) becomes expressed and alters gene expression patterns [10, 11].”
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
Guo, C. C., Majewski, T., Zhang, L., Yao, H., Bondaruk, J. E., Wang, Y., Zhang, S., Wang, Z., Lee, J. G., Lee, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.048 · Cited by 163
The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
Malaguarnera, R., & Belfiore, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00010 · Cited by 143
Wang, H., Zhang, G., Zhang, H., Zhang, F., Zhou, B., Ning, F., Wang, H.-S., Cai, S.-H., & Du, J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.004 · Cited by 142
Nyabi, O., Naessens, M., Haigh, K., Gembarska, A., Goossens, S., Maetens, M., Clercq, S. D., Drogat, B., Haenebalcke, L., Bartunkova, S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp112 · Cited by 173
Nagaharu, K., Zhang, X., Yoshida, T., Katoh, D., Hanamura, N., Kozuka, Y., Ogawa, T., Shiraishi, T., & Imanaka‐Yoshida, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.015 · Cited by 162
Metastatic Progression of Prostate Cancer and E-Cadherin
Putzke, A. P., Ventura, A. P., Bailey, A. M., Akture, C., Opoku‐Ansah, J., Çeliktaş, M., Hwang, M. S., Darling, D. S., Coleman, I. M., Nelson, P. S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.028 · Cited by 162
Metadata
- Authors
- Peinado, H., Olmeda, D., & Cano, A.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Cano, Amparo
- Venue
- Nature reviews. Cancer
- Published
- 2007-05-17
- Volume
- 7
- Issue
- 6
- Pages
- 415-428
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2025647419
- Cited by
- 3,121
- References
- 178
- Citations by year
- 2026: 38 · 2025: 64 · 2024: 75 · 2023: 108 · 2022: 107 · 2021: 158 · 2020: 165 · 2019: 181 · 2018: 205 · 2017: 218 · 2016: 237 · 2015: 201 · 2014: 226 · 2013: 225 · 2012: 237
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Fundación Científica Asociación Española Contra el Cáncer
- Ministerio de Economía y Competitividad
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- snails, ZEB, bHLH transcription factors, epithelial-mesenchymal transition, E-cadherin repression, tumor progression, epithelial phenotype, metastasis
- MeSH terms
- Snail Family Transcription Factors, Zinc Finger E-box-Binding Homeobox 1, Cell Adhesion, Cell Movement, Epithelium, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasms, Phenotype, Protein Processing, Post-Translational, Repressor Proteins, Transcription Factors, Signal Transduction, Cadherins, Homeodomain Proteins, Disease Progression, Helix-Turn-Helix Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.